Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-16

Clinical Trial Update: Optimal Tailored Treatment for H. Pylori Infection [NA]

View source ↗

Summary

The clinical trial investigating tailored treatment for Helicobacter pylori infection has been withdrawn. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Incheon St.Mary's Hospital | Conditions: Helicobacter Pylori Infection, Antibiotic Resistant Infection | NA | Status: WITHDRAWN